ATX inhibitor 12 (化合物 20) 是一种口服有效的ATX抑制剂，其IC50为 1.72 nM。ATX inhibitor 12 在 C57Bl/6J 小鼠中口服剂量为 60 mg/kg 时，可有效缓解肺结构损伤，减少纤维化病变。ATX inhibitor 12 可用于特发性肺纤维化 (IPF) 的研究。

ATX inhibitor 12 (compound 20) is an orally active and potent ATX (autotaxin) inhibitor, with an IC 50 of 1.72 nM. ATX inhibitor 12 effectively alleviates lung structural damage with fewer fibrotic lesions at an oral dose of 60 mg/kg in C57Bl/6J mice. ATX inhibitor 12 can be uesd for idiopathic pulmonary fibrosis (IPF) research [1].

C30H34FN5O2

515.62

(< 1 mg/ml refers to the product slightly soluble or insoluble )
Powder: -20°C for 3 years
In solvent: -80°C for 2 years